Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Phil Rivers Technology raises $30M in a Series A round led by venture capital and private equity firms, enhancing its AI-powered drug development platform.
PRIVATEAug 13, 2026•about 2 hours ago
Amount Raised
$30 Million
Round Type
Series A
ChinaBiotechnologyArtificial IntelligenceMachine LearningPharmaceuticalDescription
Phil Rivers Technology, a Chinese AI-driven drug developer, has raised $30 million in a Series A round backed by venture capital and private equity firms. The financing was announced on 5 August 2026. This funding ranks in the 91st percentile among Series A deals in China's health sector. Investor appetite for AI-led drug discovery in China continues to grow.
Don't miss Phil Rivers Technology's next move
Get an email the moment Phil Rivers Technology raises, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Funding Insights
Based on industry dataTypical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech